A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
Clinical trial NCT04641676 · UNKNOWN
Trial details
- NCT number
- NCT04641676
- Sponsor
- The Belgian Society of Medical Oncology
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2022-09-15
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.